-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
-
Summary
-
Sonoma Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance history and growth rate from Q1 2012 to Q1 2024.
- Sonoma Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending March 31, 2024 was $1.3M, a 15.2% increase year-over-year.
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Growth (%)